OUTSMARTING AWARD PROGRAM

Our OutSmarting Osteosarcoma 2026 LOI submission period will open on September 24, 2025. LOIs are due October 24, 2025. Invitations for full applications will be sent in early December. Full applications are due January 25, 2026.
‍
The OutSmarting Osteosarcoma Hero Award
$100,000 grant over one year to investigators with a compelling study that will Make It Better for osteosarcoma patients.

The OutSmarting Osteosarcoma Young Investigator (YI) Hope Award
$50,000 grant over one year to young investigators with a compelling study that will Make It Better for osteosarcoma patients.

Awards may be sponsored by one MIB Agents Family Fund or individual donor, which is co-branded in honor of the Family Fund. The number of grants by award type will be determined based on budget and program goals during programmatic review.

ABOUT THE OUTSMARTING OSTEOSARCOMA GRANT PROGRAM

$2,500,000 awarded to date
Launched in 2017 and powered by MIB Agents Family Funds, the OutSmarting Osteosarcoma Research Grant has fueled discovery by awarding $2.5 million to 32 dedicated investigators working to advance osteosarcoma research.

Family Funds Supporting Science
Collaboration among the scientific and patient community is a defining hallmark of MIB Agents. Our OutSmarting Osteosarcoma grants are made possible by MIB Agents Family Funds, established by osteosarcoma patients and families who raise funds in honor of an OsteoWarrior or OsteoAngel. Their dedication to Making It Better and to advancing collaboration and education within the scientific community makes every MIB Agents award deeply meaningful.
‍
Our collaborative and robust review process
The review process results in a robust and collaborative review process that uniquely incorporates patient and family perspective.

Please email christina@mibagents.org with any questions.

Download the OutSmarting Osteosarcoma Overview